Back to User profile » Mrs Monica Salamea
Paper published by Mrs Monica Salamea:
Original Research
A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (µ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty
Singla N, Minkowitz HS, Soergel DG, Burt DA, Subach RA, Salamea MY, Fossler MJ, Skobieranda F
Journal of Pain Research 2017, 10:2413-2424
Published Date: 6 October 2017